Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Several people detained in India's Gen Z-led protests against voter roll changes
Trump shares Republican senator's phone number in feud over time switch
Saudi Arabia says shrapnel from intercepted ballistic missile in Asir injures one
Israeli strike kills five in Gaza, health officials say
Nine injured in Australia as car crashes into crowd north of Sydney
